About ASSO International Consulting
ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project.
Global Medical Radioisotopes Strategic Research Report 2022
Global Medical Radioisotopes Strategic Research Report 2022-2028 by Regions, by Types, by Application
Hard Copy: 3600 USD
PDF Copy (single user): 3600 USD
Multi User License: 5400 USD
Enterprise wide License: 7200 USD
Pages: 116
Tables and Figures: 146
Published Date: Jan. 2022
Publisher:ASSO International Consulting, Inc.
Contact: Email: sales@assointernationalconsulting.com; contact@assointernationalconsulting.com
Summary
More businesses in the market research, data and insights industry are working toward a step change in their speed, efficiency and product innovation. This has led to a wider demand for more sophisticated and integrated solutions to meet the complex needs of larger established businesses and also newer, hyper-growth and technology-driven companies. ASSO's research report helps decision makers gain insight into market conditions and future trends.
To analyze and research the Medical Radioisotopes sales, revenue, consumption, status and forecast.
To focus on the key Medical Radioisotopes manufacturers and study the sales, value, market share and development plans in next few years.
To define, describe and forecast the market by type, application.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
Global Medical Radioisotopes Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
The major players in global market include
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Medical Radioisotopes in these regions, from 2013 to 2024 (forecast), covering
North America (United States,Canada, Mexico)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Other Regions )
Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
South America (Brazil. Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, U.A.E, Other Regions)
On the basis of product, the Medical Radioisotopes market is primarily split into
Tc-99m
Cobalt-60
Iodine Radioisotopes
On the basis on the end users/applications, this report covers
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
Table of Contents
1 Target Product and Background
1.1 Product Overview Medical Radioisotopes
1.2 Research Method
1.3 Data Source
1.4 Project Cycle
1.5 Forecast Data Base & Factor
1.6 Macroeconomic Development Trends
1.7 Impact of COVID-19 on the Economy and Medical Radioisotopes Industry
1.7.1 Post-COVID-19 era
1.7.2 The Impact of COVID-19 on Medical Radioisotopes Industry
2 Manufacturers Competitive Analysis of Major Players
2.1 Competitive Segmentation Analysis of Key Players
2.2 2017-2022 Key Players Sales Volume and Market Positions
2.3 Key Players Revenue and Market Positions
3 Medical Radioisotopes Sales Segment Analysis by Type
3.1 Overview
3.1.1 Tc-99m
3.1.2 Cobalt-60
3.1.3 Iodine Radioisotopes
3.2 2017-2028 Global Medical Radioisotopes Sales Volume Segment Analysis by Type
3.3 2017-2028 Global Medical Radioisotopes Revenue Segment Analysis by Type
4 Medical Radioisotopes Sales Segment Analysis End User
4.1 Introduction
4.1.1 Nuclear Therapy
4.1.2 Equipment Radioactive Source
4.1.4 Others
4.2 2017-2028 Global Medical Radioisotopes Sales Volume Segment Analysis by End User
4.3 2017-2028 Global Medical Radioisotopes Revenue Segment Analysis by End User
5 Medical Radioisotopes Market Analysis, by Region by Country
5.1 Global Medical Radioisotopes Market Size and Regional Analysis
5.2 Global Medical Radioisotopes Retrospective Market Scenario in Revenue by Region: 2017-2022
5.3 North America Market Size and Regional Analysis
5.3.1 North America Sales by Country
5.3.2 North America Medical Radioisotopes Revenue by Country
5.4 Europe Market Size and Regional Analysis
5.4.1 Europe Medical Radioisotopes Sales by Country
5.4.2 Europe Medical Radioisotopes Revenue by Country
5.5 Asia Pacific Market Size and Regional Analysis
5.5.1 Asia Pacific Medical Radioisotopes Sales by Region
5.5.2 Asia Pacific Medical Radioisotopes Revenue by Region
5.6 South America Market Size and Regional Analysis
5.6.1 South America Medical Radioisotopes Sales by Country
5.6.2 South America Medical Radioisotopes Revenue by Country
5.7 Middle East and Africa Market Size and Regional Analysis
5.7.1 Middle East and Africa Medical Radioisotopes Sales by Country
5.7.2 Middle East and Africa Medical Radioisotopes Revenue by Country
6 Medical Radioisotopes SWOT and Driving Factor Analysis
6.1 SWOT Analysis
6.2 Marketing Strategy
6.3 Technology Driven Market
6.4 Medical Radioisotopes Growth Drivers
6.5 Medical Radioisotopes Market Challenges
6.6 Medical Radioisotopes Market Restraints
7 Medical RadioisotopesRaw Material Supply and Industry Chain Analysis
7.1 Medical Radioisotopes Key Raw Material Supply
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Medical Radioisotopes Industrial Chain Analysis and Reconstruction
8 Global Medical Radioisotopes Major Manufacturers Analysis
8.1 NRG
8.1.1 NRG Corporate Outline
8.1.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.1.3 NRG Medical Radioisotopes Key Product Overview
8.1.4 Medical Radioisotopes Key Product Overview
8.1.5 NRG Business Segmentation SWOT Analysis
8.2 IRE
8.2.1 IRE Corporate Outline
8.2.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.2.3 IRE Medical Radioisotopes Key Product Overview
8.2.4 Medical Radioisotopes Key Product Overview
8.2.15IRE Business Segmentation SWOT Analysis
8.3 ANSTO
8.3.1 ANSTO Corporate Outline
8.3.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.3.3 Medical Radioisotopes Key Product Overview
8.3.4 Medical Radioisotopes Key Product Overview
8.3.5 ANSTO Business Segmentation SWOT Analysis
8.4 NTP Radioisotopes
8.4.1 NTP Radioisotopes Corporate Outline
8.4.1 NTP Radioisotopes Corporate Outline
8.4.3 Medical Radioisotopes Key Product Overview
8.4.4 Medical Radioisotopes Key Product Overview
8.4.5 NTP Radioisotopes Business Segmentation SWOT Analysis
8.5 China National Nuclear Corporation
8.5.1 China National Nuclear Corporation Corporate Outline
8.5.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.5.3 Medical Radioisotopes Key Product Overview
8.5.4 Medical Radioisotopes Key Product Overview
8.5.5 China National Nuclear Corporation Business Segmentation SWOT Analysis
8.6 Rosatom
8.6.1 Rosatom Corporate Outline
8.6.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.6.3 Medical Radioisotopes Key Product Overview
8.6.4 Medical Radioisotopes Key Product Overview
8.6.5 Rosatom Business Segmentation SWOT Analysis
8.7 Nordion
8.7.1 Nordion Corporate Outline
8.7.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.7.3 Medical Radioisotopes Key Product Overview
8.7.4 Medical Radioisotopes Key Product Overview
8.7.5 Nordion Business Segmentation SWOT Analysis
8.8 Eckert & Ziegler Strahlen
8.8.1 Eckert & Ziegler Strahlen Corporate Outline
8.8.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.8.3 Medical Radioisotopes Key Product Overview
8.8.4 Medical Radioisotopes Key Product Overview
8.8.5 Eckert & Ziegler Strahlen Business Segmentation SWOT Analysis
8.9 Polatom
8.9.1 Polatom Corporate Outline
8.9.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
8.9.3 Medical Radioisotopes Key Product Overview
8.9.4 Medical Radioisotopes Key Product Overview
8.9.5 Polatom Business Segmentation SWOT Analysis
9 Medical Radioisotopes Report Conclusion and Strategy
10 Appendix
10.1 Order and After-sales Service
10.2 Author List
10.3 Disclaimer
List of Tables
Table 1. Competitive Segmentation Analysis of Key Players
Table 2. 2017-2022 Key Players Sales Volume and Market Positions (K Units)
Table 3. 2017-2022 Key Players Revenue and Market Positions (US$ Million)
Table 4. Global Medical Radioisotopes Market Size Comparison by Type (2022-2028)
Table 5. Analysis of the Distribution of Main Players' Product Types
Table 6. 2017-2028 Global Medical Radioisotopes Sales Volume Segment Analysis by Type (K Units)
Table 7. 2017-2028 Global Medical Radioisotopes Sales Volume Share by Type
Table 8. 2017-2028 Global Medical Radioisotopes Revenue Segment Analysis by Type (US$ Million)
Table 9. Global Medical Radioisotopes Revenue Share by Type (2017-2022)
Table 10. Competitive Segmentation Analysis of Key Players
Table 11. Global Medical Radioisotopes Market Size Comparison by End User (2022-2028)
Table 12. 2017-2028 Global Medical Radioisotopes Sales Volume Segment Analysis by End User (K Units)
Table 13. 2017-2028 Global Medical Radioisotopes Sales Volume Share by End User
Table 14. 2017-2028 Global Medical Radioisotopes Revenue Segment Analysis by End User (US$ Million)
Table 15. Global Medical Radioisotopes Revenue Share by End User (2017-2022)
Table 16. 2017-2028 Global Segment: Medical Radioisotopes Sales Volume Market, by Region (K Units)
Table 17. 2017-2028 Global Segment: Medical Radioisotopes Sales Volume Market Share, by Region
Table 18. 2017-2028 Global Segment: Medical Radioisotopes Revenue Market, by Region (US$ Million)
Table 19. 2017-2028 Global Segment: Medical Radioisotopes Revenue Market Share, by Region
Table 20. 2017-2022E North America Segment: Medical Radioisotopes Sales Volume Market, by Country (K Units)
Table 21. 2017-2022E North America Segment: Medical Radioisotopes Revenue Market, by Country (US$ Million)
Table 22. 2017-2022E Europe Segment: Medical Radioisotopes Sales Volume Market, by Country (K Units)
Table 23. 2017-2022E Europe Segment: Medical Radioisotopes Revenue Market, by Country (US$ Million)
Table 24. 2017-2022E Asia Pacific Segment: Medical Radioisotopes Sales Volume Market, by Country (K Units)
Table 25. 2017-2022E Asia Pacific Segment: Medical Radioisotopes Revenue Market, by Country (US$ Million)
Table 26. 2017-2022E South America Segment: Medical Radioisotopes Sales Volume Market, by Country (K Units)
Table 27. 2017-2022E South America Segment: Medical Radioisotopes Revenue Market, by Country (US$ Million)
Table 28. 2017-2022E Middle East and Africa Segment: Medical Radioisotopes Sales Volume Market, by Country (K Units)
Table 29. Middle East and Africa Medical Radioisotopes Revenue Market Share in 2021, by Country (% Share)
Table 30. 2017-2022E Middle East and Africa Segment: Medical Radioisotopes Revenue Market, by Country (US$ Million)
Table 31. Medical Radioisotopes Growth Drivers
Table 32. Key Suppliers of Raw Materials
Table 33. NRG Corporate Outline
Table 34. NRG Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 35. NRG Key Product Overview
Table 36. IRE Corporate Outline
Table 37. IRE Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 38. IRE Key Product Overview
Table 39. ANSTO Corporate Outline
Table 40. ANSTO Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 41. ANSTO Key Product Overview
Table 42. NTP Radioisotopes Corporate Outline
Table 43. NTP Radioisotopes Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 44. NTP Radioisotopes Key Product Overview
Table 45. China National Nuclear Corporation Corporate Outline
Table 46. China National Nuclear Corporation Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 47. China National Nuclear Corporation Key Product Overview
Table 48. Rosatom Corporate Outline
Table 49. Rosatom Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 50. Rosatom Key Product Overview
Table 51. Nordion Corporate Outline
Table 52. Nordion Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 53. Nordion Key Product Overview
Table 54. Eckert & Ziegler Strahlen Corporate Outline
Table 55. Eckert & Ziegler Strahlen Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 56. Eckert & Ziegler Strahlen Key Product Overview
Table 57. Polatom Corporate Outline
Table 58. Polatom Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2022)
Table 59. Polatom Key Product Overview
List of Tables and Figures
Figure 1. Product Picture of Medical Radioisotopes
Figure 2. Proportion of GDP of Major Countries in the World in 2018
Figure 3. Figure Projected Growth Profiles for Major Economies – Regression to the Mean
Figure 4. Figure Key Economies’ Share of World GDP in PPP Terms
Figure 5. Global Economic Forecast in 2050
Figure 6. Global GDP Forecast by Region to 2050
Figure 7. Climate Change Impact on Level of GDP in 2050
Figure 8. Economic Impact of COVID-19 on Major Economies in 2021
Figure 9. IMF's Latest Global Economic Forecast by 2022Q1
Figure 10. Comparative Analysis of the Direct Impact of COVID-19 on the Industry (US$ Million)
Figure 11. Characteristics of the Impact of COVID-19 on the Industry
Figure 12. Key Players Revenue Volume Share in 2021
Figure 13. Global Medical Radioisotopes Revenue Share by Manufacturers in 2021
Figure 14. Market Size Share Comparison by End User
Figure 15. Global Medical Radioisotopes Market Size by Region in 2021
Figure 16. Global Medical Radioisotopes Market Size by Region: 2017 VS 2021 VS 2028
Figure 17. Global Medical Radioisotopes Market Size 2017-2028 (US$ Million)
Figure 18. Global Medical Radioisotopes Market Size 2017-2028 (US$ Million)
Figure 19. 2017-2028 Global Segment: Medical Radioisotopes Sales Volume Market Share, by Region
Figure 20. 2017-2028 Global Segment: Medical Radioisotopes Revenue Market Share, by Region
Figure 21. North America Medical Radioisotopes Key Player Distribution Analysis
Figure 22. North America Medical Radioisotopes Revenue Market Share in 2021, by Country (% Share)
Figure 23. Europe Medical Radioisotopes Key Player Distribution Analysis
Figure 24. Europe Medical Radioisotopes Revenue Market Share in 2021, by Country (% Share)
Figure 25. Asia Pacific Medical Radioisotopes Key Player Distribution Analysis
Figure 26. Asia Pacific Medical Radioisotopes Revenue Market Share in 2021, by Country (% Share)
Figure 27. South America Medical Radioisotopes Key Player Distribution Analysis
Figure 28. South America Medical Radioisotopes Revenue Market Share in 2021, by Country (% Share)
Figure 29. Middle East and Africa Medical Radioisotopes Key Player Distribution Analysis
Figure 30. Medical Radioisotopes Industry SWOT Analysis
Figure 31. Figure Marketing Strategy
Figure 32. Medical Radioisotopes Technology Development Trend
Figure 33. Global Stars: The Most Innovative Countries, Ranked by Income Group in 2019
Figure 34. Leading countries by gross research and development (R&D) expenditure worldwide in 2021(in billion U.S. dollars)
Figure 35. Medical Radioisotopes Industrial Chain Analysis
Figure 36. FDI, trade, GDP and GVC trends, 1990–2019
Figure 37. World Carbon Dioxide Emissions from 2009 to 2019, by region (in Million Metric Tons of Carbon Dioxide)
Figure 38. Global Energy Structure Evolution Structure
Figure 39. The Evolution of Global Road Vehicles to 2050
Figure 40. NRG SWOT Analysis
Figure 41. IRE SWOT Analysis
Figure 42. ANSTO SWOT Analysis
Figure 43. NTP Radioisotopes SWOT Analysis
Figure 44. China National Nuclear Corporation SWOT Analysis
Figure 45. Rosatom SWOT Analysis
Figure 46. Nordion SWOT Analysis
Figure 47. Eckert & Ziegler Strahlen SWOT Analysis
Figure 48. Polatom SWOT Analysis
ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project. We will go all out and never give up. ASSO regards each other's excellence as the purpose of our service. ASSO's services involve regional analysis, market data, player share, market decision-making, marketing and product positioning
– Allen King
Leave a comment
All fields marked with an asterisk (*) are required